Europe

View All
Lindis Biotech gets positive CHMP Opinion for Korjuny in the EU
October 21, 2024 0

Lindis Biotech gets positive CHMP Opinion for Korjuny in the EU

By Dino Mustafić

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Lindis Biotech's trifunctional Korjuny (catumaxomab), anti-CD3...

SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating the Company’s Lead Development Program SR-878

SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating the Company’s Lead Development Program SR-878

October 18, 2024 Off
NVDX3 can address unmet needs of patients with bone defects

NVDX3 can address unmet needs of patients with bone defects

October 18, 2024 Off

USA

View All
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares
June 12, 2024 Off

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares

By Author

ProKidney Corp., a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an underwritten public offering and a concurrent registered direct offering of...

Opdivo plus Yervoy demonstrated improved survival benefit

Opdivo plus Yervoy demonstrated improved survival benefit

June 7, 2024 Off
Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

January 2, 2024 Off

My Pharmaceutical

View All
Brenntag celebrates the company’s 150th anniversary in Essen, Germany
October 18, 2024 Off

Brenntag celebrates the company’s 150th anniversary in Essen, Germany

By Author

Brenntag, the global market leader in chemicals and ingredients distribution, held a celebration to mark its 150-year anniversary yesterday in Essen, Germany, where the DAX40 company is headquartered.

Over-65s to benefit from potentially life-changing new treatment options thanks to technology-powered clinical trials initiative from Cera
October 18, 2024 Off

Over-65s to benefit from potentially life-changing new treatment options thanks to technology-powered clinical trials initiative from Cera

By Dino Mustafić

Over-65s across the UK are set to benefit from potentially life-changing new treatment options for conditions like cancer and cardiovascular...

SLEEVER and CARBIOS globally launch world’s first Home Compost biodegradable tamper evident seal: SEELCAP ONEGO
September 25, 2024 Off

SLEEVER and CARBIOS globally launch world’s first Home Compost biodegradable tamper evident seal: SEELCAP ONEGO

By Dino Mustafić

SLEEVER®, a French family-owned group International SME and innovative leader in shrinksleeve label technology, and CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the...




Lindis Biotech gets positive CHMP Opinion for Korjuny in the EU
October 21, 2024 0

Lindis Biotech gets positive CHMP Opinion for Korjuny in the EU

By Dino Mustafić

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Lindis Biotech’s trifunctional Korjuny (catumaxomab), anti-CD3 x anti-EpCAM antibody (trAb) for the intraperitoneal treatment of malignant ascites (MA) in adults with EpCAM-positive carcinomas who are not eligible for further systemic anticancer therapy.